Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0273 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0273 | 0.5 | 0.5 |
Trypanosoma brucei | oxidoreductase-like protein | 0.0273 | 0.5 | 0.5 |
Toxoplasma gondii | 2,4-dienoyl CoA reductase 2, peroxisomal family protein | 0.0273 | 0.5 | 0.5 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0273 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0273 | 0.5 | 0.5 | |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0273 | 0.5 | 0.5 |
Mycobacterium ulcerans | 3-alpha-hydroxysteroid dehydrogenase | 0.0273 | 0.5 | 0.5 |
Mycobacterium ulcerans | short chain dehydrogenase | 0.0273 | 0.5 | 0.5 |
Leishmania major | oxidoreductase-like protein | 0.0273 | 0.5 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.